New Insights Into Acute Lymphoblastic Leukemia

This title is printed to order. This book may have been self-published. If so, we cannot guarantee the quality of the content. In the main most books will have gone through the editing process however some may not. We therefore suggest that you be aware of this before ordering this book. If in doubt check either the author or publisher’s details as we are unable to accept any returns unless they are faulty. Please contact us if you have any questions.

The shining example of medical growth and curing ability is the case of acute lymphoblastic leukemia (ALL). Nearly forty years back, ALL was deemed fatal; it is today regarded as highly curable. Despite the minor inconsistency in results between children and adults, continuous efforts are in place to improve the shortcomings in the treatment of adults diagnosed with ALL. The success story of ALL treatment can be accredited to better understanding of the disease, availability of medicinal drugs and countless trials to overcome the disease. A disease as complex as ALL has several facets, involving complex therapy for treatment. The primary and the generic components of ALL have been covered thoroughly in the book, comprising of how epidemiology of ALL affects Hispanics, its ophthalmologic manifestations, current therapy and also research on drug-resistance. Sub-topics include biological pathways, development of new drugs, experimentation with long-term uses of CNS prophylaxis and its therapy.